#amylyx — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #amylyx, aggregated by home.social.
-
#Amylyx They're "surprised" by the results? I call bullshit. The results from Phase II, that they relied on for the original approval through a questionable process, were shaky at best and the rule in pharma is that the results _never_ get better in later trials.
-
#Amylyx They're "surprised" by the results? I call bullshit. The results from Phase II, that they relied on for the original approval through a questionable process, were shaky at best and the rule in pharma is that the results _never_ get better in later trials.
-
#Amylyx They're "surprised" by the results? I call bullshit. The results from Phase II, that they relied on for the original approval through a questionable process, were shaky at best and the rule in pharma is that the results _never_ get better in later trials.
-
#Amylyx They're "surprised" by the results? I call bullshit. The results from Phase II, that they relied on for the original approval through a questionable process, were shaky at best and the rule in pharma is that the results _never_ get better in later trials.
-
$158,000 ALS drug pulled from market after failing in large clinical trial - Enlarge (credit: Amlyx)
Amylyx, the maker of a new drug to tre... - https://arstechnica.com/?p=2015321 #clinicaltrial #science #health #amylyx #als #fda
-
$158,000 ALS drug pulled from market after failing in large clinical trial - Enlarge (credit: Amlyx)
Amylyx, the maker of a new drug to tre... - https://arstechnica.com/?p=2015321 #clinicaltrial #science #health #amylyx #als #fda
-
$158,000 ALS drug pulled from market after failing in large clinical trial - Enlarge (credit: Amlyx)
Amylyx, the maker of a new drug to tre... - https://arstechnica.com/?p=2015321 #clinicaltrial #science #health #amylyx #als #fda
-
$158,000 ALS drug pulled from market after failing in large clinical trial - Enlarge (credit: Amlyx)
Amylyx, the maker of a new drug to tre... - https://arstechnica.com/?p=2015321 #clinicaltrial #science #health #amylyx #als #fda
-
$158,000 ALS drug pulled from market after failing in large clinical trial - Enlarge (credit: Amlyx)
Amylyx, the maker of a new drug to tre... - https://arstechnica.com/?p=2015321 #clinicaltrial #science #health #amylyx #als #fda
-
Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail—FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal—Novo Nordisk pushes back after price gouging accusations by Bernie Sanders--http://bit.ly/w28kSd #als #amylyx #relyvrio #ftc #bostonscientific #novonordisk #berniesanders #drugpricing #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail—FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal—Novo Nordisk pushes back after price gouging accusations by Bernie Sanders--http://bit.ly/w28kSd #als #amylyx #relyvrio #ftc #bostonscientific #novonordisk #berniesanders #drugpricing #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail—FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal—Novo Nordisk pushes back after price gouging accusations by Bernie Sanders--http://bit.ly/w28kSd #als #amylyx #relyvrio #ftc #bostonscientific #novonordisk #berniesanders #drugpricing #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
#Amylyx stock price charts on #NASDAQ
explain how one of these speculative bubbles is ballooned in response to a new therapy thanks to #VentureCapital
After the fiasco, listed company fell by 80% in days to be worth uS$ 200 million
In coming days it will drop by half. -
#Amylyx stock price charts on #NASDAQ
explain how one of these speculative bubbles is ballooned in response to a new therapy thanks to #VentureCapital
After the fiasco, listed company fell by 80% in days to be worth uS$ 200 million
In coming days it will drop by half. -
Amylyx Pharmaceuticals is a #BioTech #SpinOff of #BrownUniversity -#Providence,#RhodeIsland,USA
that raised uS$ 2.2 million in 2022 from the #ALS Association
through the Ice Bucket Challenge
- it went viral in 2014 -
In 2022 Jan #Amylyx goes public and in Nov. now failed #Relyvrio was approved by US Food and Drugs Administration
http://bit.ly/43qnnIj -
Amylyx Pharmaceuticals is a #BioTech #SpinOff of #BrownUniversity -#Providence,#RhodeIsland,USA
that raised uS$ 2.2 million in 2022 from the #ALS Association
through the Ice Bucket Challenge
- it went viral in 2014 -
In 2022 Jan #Amylyx goes public and in Nov. now failed #Relyvrio was approved by US Food and Drugs Administration
http://bit.ly/43qnnIj -
http://bit.ly/490a7eA
Months ago I was writing about scientific fraud, #BioPharma,new #Drugs and #VentureCapital It is only part of huge #Fraud and #Quackery
Today it is published that in clinical trial, #Relyvrio
of #Amylyx Pharmaceutical, a therapy against amyotrophic lateral sclerosis does not work -
http://bit.ly/490a7eA
Months ago I was writing about scientific fraud, #BioPharma,new #Drugs and #VentureCapital It is only part of huge #Fraud and #Quackery
Today it is published that in clinical trial, #Relyvrio
of #Amylyx Pharmaceutical, a therapy against amyotrophic lateral sclerosis does not work -
http://bit.ly/490a7eA
Months ago I was writing about scientific fraud, #BioPharma,new #Drugs and #VentureCapital It is only part of huge #Fraud and #Quackery
Today it is published that in clinical trial, #Relyvrio
of #Amylyx Pharmaceutical, a therapy against amyotrophic lateral sclerosis does not work